Skip to main content

Maria Pilar Delgado Martínez

Institutions of which they are part

Main researcher
Neurovascular Diseases
Vall Hebron Institut de Recerca

Maria Pilar Delgado Martínez

Institutions of which they are part

Main researcher
Neurovascular Diseases
Vall Hebron Institut de Recerca

Projects

INVICTUS

IP: Joan Montaner Villalonga
Collaborators: Marta Aurora Rubiera Del Fueyo, Jorge Pagola Pérez Blanca, José Alvarez Sabin, Anna Penalba Morenilla, Maria Mar Hernandez Guillamon, Marc Ribó Jacobi, Maria Pilar Delgado Martínez, Carlos Molina Cateriano, Anna Rosell Novel, David Rodriguez Luna, Mª Ángeles Muchada López, Estevo Santamarina Pérez
Funding agency: Instituto de Salud Carlos III
Funding: 247695.66
Reference: RD12/0014/0005
Duration: 01/01/2013 - 31/03/2017

GODS project: Genetic contribution to functional Outcome and Disability after Stroke

IP: -
Collaborators: Maria Pilar Delgado Martínez
Funding agency: Fundació La Marató de TV3
Funding: 68988.52
Reference: MARATV3-2011-112034
Duration: 16/03/2012 - 15/03/2015

Influence of proteases before, during and after stroke (ERANET- PROTEA)

IP: Joan Montaner Villalonga
Collaborators: Anna Penalba Morenilla, Maria Pilar Delgado Martínez, Anna Rosell Novel
Funding agency: Ministerio de Ciencia e Innovación-MICINN
Funding: 150000
Reference: PRI-PIMNEU-2011-1352 (PROTEA)
Duration: 01/12/2011 - 01/12/2014

Ministerio de Ciencia

Estudio comparativo del uso de fármacos, cumplimiento terapéutico y control de la presión arterial en una cohorte de hipertensos en Atención Primaria

IP: Joan Montaner Villalonga
Collaborators: Maria Pilar Delgado Martínez
Funding agency: Ministerio Sanidad
Funding: 80000
Reference: EC10-336
Duration: 01/01/2011 - 31/12/2013

Related news

For three days, the III Stroke Congress of the national RICORS-ICTUS network and a symposium focused on cerebral haemorrhage were held.

The TOUCH MSCA-COFUND doctoral training programme, led by UAB and focusing on the field of mental health, has opened its first call for applications, offering 13 doctoral positions.

The Cardiovascular Diseases and Neurovascular Diseases groups at VHIR will investigate new therapeutic strategies for heart failure, nanomedicine in stroke and the prevention of cardiovascular toxicity in the case of oncological treatments.

Related professionals

Santos Ortega, Alba

Santos Ortega, Alba

Predoctoral researcher
Cardiovascular Diseases
Read more
Xavier Cañas Perea

Xavier Cañas Perea

Director/a d'Àrea
Clinical Research Development Directorate
Read more
Ruiz Esteve, Fernando

Ruiz Esteve, Fernando

Research technician
Neurovascular Diseases
Read more
Marcos Prieto, Susana

Marcos Prieto, Susana

Research technician
Molecular Medical Imaging
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.